Neurodegenerative Disorder-Targeting Compound 1

• UNSPSC Description:

  Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63[1].

• Target Antigen:

  Proteasome

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/Neurodegenerative-Disorder-Targeting-Compound-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C([C@@H](CC1)N(CC2=CC=CC=C2)C1=O)NC(CC3=CC=CC=C3)C(C(NCC4=NC=CC=C4)=O)=O

• Molecular Weight:

  484.55

• References & Citations:

  [1]Helmut Mack, et al. Carboxamide compounds and their use as calpain inhibitors. WO2010128102A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1254698-39-9